Benzinga | Aug 12, 2021 05:17PM EDT

Vivos Therapeutics Q2 EPS $(0.19) Misses $(0.18) Estimate, Sales $4.50M Beat $3.60M Estimate

Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.18) by 5.56 percent. The company reported quarterly sales of $4.50 million which beat the analyst consensus estimate of $3.60 million by 25.00 percent.